We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Medical exposure to micro(nano)plastics: An exposure pathway with potentially significant harm to human health that should not be overlooked.
Summary
This paper identifies medical procedures — including intravenous infusions, dialysis, and surgical implants — as an underrecognized pathway for direct human exposure to micro- and nano-plastics. The authors argue that the medical community needs to assess and reduce plastic particle exposure from clinical materials and devices.
Micro(nano)plastics (MNPs) are an emerging type of contaminants that are widely present in the environments that people live in. MNPs can enter the human body in a variety of pathways, but the three main ones are through dietary intake, air inhalation, and skin contact. However, it has been discovered that medical plastics used in medical activities also pose potential risks to MNPs exposure as exposure pathways are continuously refined and clarified. Unfortunately, there is currently insufficient study on the exposure of medical plastics and MNPs, and exposure risks and potential health problems are frequently overlooked. This study aimed to close this research gap by searching the databases of China National Knowledge Infrastructure (CNKI), PubMed, and Web of Science for relevant literature. It then filtered out publications that contained information relevant to keywords such as micro(nano)plastics, medical plastics, exposure pathways, and human health in order to do analysis and summary. We discovered that medical plastics are a high-risk source of direct MNPs exposure to the human body, and this exposure could pose a potential harm to human health. Because of the potential harm to human health, this work presents the medical exposure of MNPs for the first time and calls for more research and attention on this vital area.
Sign in to start a discussion.
More Papers Like This
Plastic particles in medicine: A systematic review of exposure and effects to human health
Medical plastics including bags, containers, and administration sets release micro- and nanoplastics along with chemical additives that can interact with pharmaceutical constituents, creating an understudied route of direct human exposure. Both primary exposure (during medical treatment) and secondary environmental exposure (from hospital plastic waste disposal) represent potential health hazards.
Microplastic particles and infusion therapy — Evidence, implications, and unanswered questions
This review highlights infusion therapy via medical devices and pharmaceutical containers as a significant but often overlooked route of microplastic exposure in humans. The study emphasizes that despite strict regulations, advances in clinical research have not been fully integrated into current industry testing standards, and calls for a standardized, multi-method approach to microplastic detection and risk assessment in medical settings.
Factors affecting micro(nano)plastic release during intravenous therapy: Direct blood exposure.
This study systematically evaluated factors affecting micro(nano)plastic (MNP) release from medical infusion products during intravenous therapy. Results indicated that MNPs are released into IV fluid at measurable levels, potentially delivering plastic particles directly into the bloodstream of patients.
Characteristics and influencing factors of microplastics entering human blood through intravenous injection
This study found that common medical devices used for intravenous injections -- syringes, infusion sets, and vein needles -- release microplastics directly into patients' bloodstreams. The dominant particles were polyethylene and polypropylene fragments, and repeated use of devices significantly increased the amount released. While the total number of particles entering the body this way is lower than from food, the direct injection into blood makes this exposure pathway especially concerning.
Is intravenous infusion an unrecognized route for internal microplastic human exposure? A general assessment
This study discovered that microplastics are present in intravenous (IV) infusion products used in hospitals, identifying a previously unrecognized route of microplastic exposure that bypasses the body's natural barriers. Standard IV filters removed some but not all of the plastic particles. This finding is important because IV-delivered microplastics go directly into the bloodstream, potentially posing a greater risk than microplastics that are eaten or inhaled.